David R. Serwitz

David R. Serwitz serves as a Contract Specialist responsible for managing the full lifecycle of procurement actions, from requirements validation and market research to contract award and administration. He plays a critical role in ensuring compliance with federal acquisition regulations while aligning purchasing decisions with mission-critical needs. His portfolio primarily encompasses high-precision scientific and pharmaceutical manufacturing acquisitions, requiring deep technical understanding and rigorous source selection processes. Serwitz routinely handles complex, performance-based contracts involving specialized equipment and proprietary manufacturing processes, often coordinating with technical evaluators and program managers to ensure deliverables meet stringent quality and regulatory standards. Serwitz maintains a broad and competitive contractor base, engaging with both large-scale manufacturers and niche suppliers capable of meeting exacting technical specifications. While no single vendor dominates his award profile, he consistently fosters relationships with firms possessing advanced capabilities in analytical instrumentation and medicinal compound production. His contracting approach emphasizes transparency, fair competition, and timely contract execution, ensuring uninterrupted supply of mission-critical materials and devices. He actively encourages responsive, compliant proposals and maintains rigorous post-award oversight to uphold contract performance. Serwitz’s procurement activity is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical excellence and industrial capacity over socioeconomic preferences, prioritizing the most capable and qualified offerors regardless of business size or certification status. While he does not target 8(a), HUBZone, or SDVOSB programs, his processes remain fully compliant with all socioeconomic contracting statutes and are designed to ensure equitable access for all eligible vendors. His primary focus lies in NAICS 325411 (Medicinal and Botanical Manufacturing) and 334516 (Analytical Laboratory Instrument Manufacturing), where he procures active pharmaceutical ingredients, botanical extracts, and precision laboratory instrumentation such as chromatographs and spectrometers. His expertise spans Good Manufacturing Practices (GMP), FDA-regulated environments, and analytical validation protocols, making him a key liaison between technical stakeholders and acquisition teams in the scientific and pharmaceutical supply chain.